Phenotypeca commence R&D with their synthetic biology platform using baker’s yeast (Saccharomyces cerevisiae).

January 2019

Phenotypeca has started a started a project to identify current manufacturing processes where yeast is used, e.g. in the production of food, food additives, enzymes, vaccines, metabolites and recombinant therapeutic proteins market and to determine which ones would benefit from the application Phenotypeca’s technology platform. That is, the production and application of next-generation yeast strains optimised through a combination of advanced yeast breeding, Quantitative Trait Loci (QTL) analysis and traditional genetic engineering.

This will be followed by subsequent design and development of R&D projects to establish which should be targets for the initial specific R&D projects in the lab, to validate the application areas and generate proof of concept data.

In parallel, with this research activity, we are in the process of establishing a robust and unique business model that to generate ongoing revenues and Intellectual Property rights to further enhance the value of this UK based business, and to complement our own R&D.